A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa

NCT00263666 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL: Rotarix
BIOLOGICAL: Placebo
BIOLOGICAL: Tritanrix-HB+Hib
BIOLOGICAL: Polio Sabin

Sponsor

GlaxoSmithKline